Charles River Laboratories International, Inc. (CRL)
Sector: Industrials
Industry: Services-Commercial Physical & Biological Research
Country: United States
Exchange: NYSE
Market cap: $13.45B
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Latest financial period: June 27, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #1232 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 1.5% | 1.5% | 1.3% | 3.7% |
Growth #1375 of 1484 companies
Payout #1084 of 1484 companies
Safety #569 of 1484 companies
Price #1227 of 1484 companies
